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Articles

National and regional estimates of term and preterm babies
born small for gestational age in 138 low-income and
middle-income countries in 2010
Anne CC Lee, Joanne Katz, Hannah Blencowe, Simon Cousens, Naoko Kozuki, Joshua P Vogel, Linda Adair, Abdullah H Baqui, Zulﬁqar A Bhutta,
Laura E Caulﬁeld, Parul Christian, Siân E Clarke, Majid Ezzati, Wafaie Fawzi, Rogelio Gonzalez, Lieven Huybregts, Simon Kariuki, Patrick Kolsteren,
John Lusingu, Tanya Marchant, Mario Merialdi, Aroonsri Mongkolchati, Luke C Mullany, James Ndirangu, Marie-Louise Newell, Jyh Kae Nien,
David Osrin, Dominique Roberfroid, Heather E Rosen, Ayesha Sania, Mariangela F Silveira, James Tielsch, Anjana Vaidya, Barbara A Willey,
Joy E Lawn, Robert E Black, for the CHERG SGA-Preterm Birth Working Group*

Summary
Background National estimates for the numbers of babies born small for gestational age and the comorbidity with
preterm birth are unavailable. We aimed to estimate the prevalence of term and preterm babies born small for
gestational age (term-SGA and preterm-SGA), and the relation to low birthweight (<2500 g), in 138 countries of low
and middle income in 2010.
Methods Small for gestational age was deﬁned as lower than the 10th centile for fetal growth from the 1991 US national
reference population. Data from 22 birth cohort studies (14 low-income and middle-income countries) and from the
WHO Global Survey on Maternal and Perinatal Health (23 countries) were used to model the prevalence of term-SGA
births. Prevalence of preterm-SGA infants was calculated from meta-analyses.
Findings In 2010, an estimated 32·4 million infants were born small for gestational age in low-income and middleincome countries (27% of livebirths), of whom 10·6 million infants were born at term and low birthweight. The
prevalence of term-SGA babies ranged from 5·3% of livebirths in east Asia to 41·5% in south Asia, and the prevalence
of preterm-SGA infants ranged from 1·2% in north Africa to 3·0% in southeast Asia. Of 18 million low-birthweight
babies, 59% were term-SGA and 41% were preterm-SGA. Two-thirds of small-for-gestational-age infants were born in
Asia (17·4 million in south Asia). Preterm-SGA babies totalled 2·8 million births in low-income and middle-income
countries. Most small-for-gestational-age infants were born in India, Pakistan, Nigeria, and Bangladesh.
Interpretation The burden of small-for-gestational-age births is very high in countries of low and middle income and
is concentrated in south Asia. Implementation of eﬀective interventions for babies born too small or too soon is an
urgent priority to increase survival and reduce disability, stunting, and non-communicable diseases.
Funding Bill & Melinda Gates Foundation by a grant to the US Fund for UNICEF to support the activities of the Child
Health Epidemiology Reference Group (CHERG).

Introduction
An estimated 20 million infants are born globally with
low birthweight (<2500 g) every year.1 Low birthweight
is an important population indicator for tracking
neonatal health and includes babies born preterm
(<37 completed weeks of gestation) and infants with
intrauterine growth restriction. These components of
low birthweight have diﬀerent causes and risks of
mortality, morbidity, impaired growth, and noncommunicable diseases. Hence, for us to guide
interventions to address both prevention and care, we
must delineate low birthweight according to preterm
birth, intrauterine growth restriction, and their overlap.
National estimates of preterm birth for 184 countries
have been published for the year 2010,2 showing a total of
14·9 million preterm births. In the Global Burden of
Disease Study,3 77 million (3·1%) disability-adjusted lifeyears were attributed to preterm birth, similar to the
burden of HIV or malaria. In 1998, de Onis and
www.thelancet.com/lancetgh Vol 1 July 2013

colleagues4 reported estimates of intrauterine growth
restriction, using babies born full term and with low
birthweight as a proxy measure. They estimated that
13·7 million babies were born at term and with low
birthweight every year, but they did not provide national
estimates.4 Furthermore, no estimates are available for
the co-occurrence of intrauterine growth restriction and
preterm birth, or the relation between intrauterine
growth restriction and the widely used metric of low
birthweight.
The classiﬁcation of small for gestational age was
deﬁned by a 1995 WHO expert committee as infants
below the 10th centile of a birthweight-for-gestational-age,
gender-speciﬁc reference population.5,6 A major challenge
is selection of an appropriate global reference. Small for
gestational age is a commonly accepted proxy measure of
intrauterine growth restriction.5 However, small for
gestational age includes babies who are constitutionally
small and in the lower tail of the growth curve, in addition
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to infants who were growth-restricted in utero because of
maternal and environmental factors, such as chronic
undernutrition,
multiple
pregnancy,
placental
insuﬃciency, pregnancy complications (eg, preeclampsia), infections, and other toxic exposures.7 In
settings with high rates of small-for-gestational-age
births, growth restriction accounts for a high proportion
of these,4 justifying its use as a proxy for intrauterine
growth restriction.
Our aim is to estimate the national prevalence and
numbers of neonates born small for gestational age at
full term (≥37 weeks; term-SGA), and the co-occurrence
of small for gestational age with preterm birth
(preterm-SGA), in 138 countries of low and middle
income. We focus on this group of countries in view of
their high burden of disease and the urgent need for data
to direct, monitor, and assess public health planning in
these regions.

Methods
Deﬁnitions
We deﬁned small for gestational age as a birthweight
lower than the 10th centile for a speciﬁc completed
gestational age by gender, using the Alexander reference
population8 (US National Center for Health Statistics,
1991; n=3 134 879 livebirths). We deﬁned term-SGA as a
baby born small for gestational age at 37 or more
completed weeks of gestation, and we classiﬁed
preterm-SGA as infants born small for gestational age at
fewer than 37 weeks of gestation. We deﬁned low
birthweight as a baby born weighing less than 2500 g.
Finally, we deﬁned appropriate for gestational age as a
birthweight on or higher than the 10th centile for
gestational age, using the Alexander reference.

Data sources
We obtained data from three sources: (1) systematic
literature reviews to identify birth cohorts with
information on birthweight and gestational age;
(2) research networks of birth cohorts; and (3) the WHO
Global Survey on Maternal and Perinatal Health.9 We
considered datasets for inclusion if they contained
information on: birthweight; gestational age measured
by last menstrual period, ultrasound, or clinical
assessment; and vital status (required for analyses
described elsewhere).10 Our exclusion criteria were:
datasets missing more than 25% of data for birthweight
or gestational age; inaccurate gestational age ascertained
by study investigators (ie, poorly linked gestational age–
birthweight data, or gestational age reported in months);
and gestational age established by symphysis fundal
height. We only included weight in analyses if the
measurement was made within 72 h of birth.
We initially searched Medline and WHO regional
databases (LILACS, AIM, and EMRO) in September,
2009, to identify potential birth cohorts with data required
for a larger scope of secondary analyses related to preterm

birth and small-for-gestational-age-related mortality
(appendix p 1).10 We identiﬁed additional datasets within
maternal-neonatal research networks (ongoing maternalnewborn health studies, demographic surveillance sites,
and WHO UNIMAPP11 studies). We contacted
investigators to ascertain whether their studies met our
inclusion criteria and, if so, we asked them to join the
Child Health Epidemiology Reference Group (CHERG)
SGA-Preterm Birth working group and contribute data
for secondary analyses (appendix pp 2–4).10 We did
another literature review in February, 2012, to identify
published studies reporting the prevalence of both smallfor-gestational-age births, using the Alexander reference,8
and low birthweight to use for statistical modelling, since
low birthweight was the primary independent modelling
predictor. We implemented two strategies: (1) a Medline
search using terms (“small-for-gestational-age” OR
“intrauterine growth restriction”) AND “low birthweight”
AND (“incidence” OR “prevalence”) AND “developing
country”; and (2) a Scopus search identifying all
published articles that have cited small for gestational
age using the Alexander reference.8 Further details on
our search strategy are in the appendix (p 5).
We also analysed data from the WHO Global Survey on
Maternal and Perinatal Health (appendix p 6),9 which
gathered data between 2004 and 2008 from 373 facilities
in 24 countries and included 290 610 births. We excluded
data from Japan (n=3318) because it is a high-income
country. Therefore, a total of 23 countries contributed to
the analysis. Details of survey methods are reported
elsewhere.9 The WHO Global Survey selected countries
randomly from every WHO subregion and then picked
facilities at random from the capital city and two other
randomly selected provinces. For this facility-based
survey, trained data collectors abstracted relevant data
from medical records into standardised forms from all
births in the facility over a speciﬁc period. Several
facilities had data with improbable values or
unrepresentative data. To exclude these poor data-quality
facilities, we omitted those with fewer than 500 births
(small sample size), preterm birth rates greater than 40%
or less than 3% (outside biological plausibility range), or
rates of low birthweight less than 1% (implausible). We
aggregated data at the country level.
Datasets analysed by the original study investigators
were approved by existing site institutional review boards.
For datasets shared with the CHERG working group,
personal identiﬁers were not included and, therefore,
were deemed exempt by the Johns Hopkins Bloomberg
School of Public Health institutional review board.

Procedures
In the ﬁrst step of the estimation process, we developed a
model to estimate the national prevalence of term-SGA,
based on the included input data. We then estimated the
prevalence of preterm-SGA, using meta-analytical
methods, and we applied these proportions to recent
www.thelancet.com/lancetgh Vol 1 July 2013

Articles

national preterm birth estimates developed by members
of our working group.2
We used Stata 11.0 for all analyses. We did randomeﬀects regression with logit(term-SGA prevalence) as the
dependent variable and study region as the clustered unit
of analysis (appendix p 7). Variables tested included:
biological factors (prevalence of low birthweight, neonatal
mortality rate); health-care access (proportion of
deliveries in a facility, proportion of births by caesarean
section, proportion of mothers with more than four
antenatal care visits); and demographic factors
(proportion of cohort in highest risk categories of
maternal age, parity, and maternal education). We created
categorical dummy variables for: degree of selection bias
(population-based or community-level recruitment,
facility-based or antenatal care recruitment with some or
minimum selection bias, tertiary care or referral facility);
study decade; and method of assessment of gestational
age (last menstrual period, ultrasound, clinical). To
examine candidate models, we included the natural log
of low-birthweight prevalence as the main predictor,
added individual predictors, and assessed for signiﬁcance
(p<0·05), improvement in adjusted R², and Akaike
information criterion. To select the ﬁnal model, we did
cross-validation12 to compare prediction accuracy between
potential models (appendix p 8).
We undertook sensitivity analyses using two datasets.
In the ﬁrst (modelling dataset A, n=45), we included all
birth cohort data. In the second restricted dataset
(modelling dataset B, n=20), we included only populationrepresentative studies, excluding facility-based studies
that might have selection bias (WHO studies,9 Pakistan
Aga Khan University [ZAB], Uganda 200513). Both
datasets A and B resulted in similar estimates of variables
and model ﬁt; thus, we present results of the larger
dataset A, which enabled cross-validation. We also did
multiple imputation14 to incorporate infants with missing
birthweight back into the individual cohort studies
(appendix p 9).
For every cohort in dataset A, we calculated the
prevalence of small-for-gestational-age babies within two
categories of preterm births: moderate-to-late preterm
(between 32 weeks and <37 weeks of gestation) and early
preterm (<32 weeks of gestation). We used randomeﬀects meta-analyses to estimate the pooled regional and
overall prevalence of infants born small for gestational
age between 32 weeks and less than 37 weeks of gestation
and those born at less than 32 weeks of gestation. We did
sensitivity analyses to look at the eﬀect of region, facilitybased versus community-based recruitment, and study
quality. We judged studies of a high quality to be those
with population-based recruitment, adequate data
capture (deﬁned as missing <15% of birthweight data
and <30% of birthweight data among neonatal deaths,
and the proportion of infants born at <32 weeks
comprising at least 5% of preterm births), and biological
plausibility (prevalence of small for gestational age >1%).
www.thelancet.com/lancetgh Vol 1 July 2013

We used the prediction model to estimate term-SGA
prevalence in countries of low and middle income
(UN Millennium Development Goal [MDG] classiﬁcation) for the year 2010. We took national neonatal
mortality rates from the UN Interagency Group for Child
Mortality Estimation15 and low-birthweight rates from
several sources (appendix p 10). To obtain the number of
small-for-gestational-age liveborn infants, we multiplied
the prevalence of term and preterm small for gestational
age by the estimated number of livebirths for 2010.16 We
used a bootstrap approach to estimate ranges of
uncertainty (appendix p 11).
In every dataset, we calculated the proportion of
term-SGA infants who were low birthweight and did
meta-analyses, using random eﬀects to pool the estimate
at the major regional level. We multiplied this value by
term-SGA estimates for every country and summarised
them regionally.

Health Services, Washington,
DC, USA (J Tielsch PhD); and
Saving Newborn Lives/Save the
Children USA, Washington, DC,
USA (J E Lawn)
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Dr Anne C Lee, Department of
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Results
The appendix shows data inputs for the estimation
process (p 12), study characteristics of the 22 CHERG
cohorts included in our study13,17–36 (pp 2–4), and survey
characteristics for the WHO datasets9 (p 6). From the
literature review, we identiﬁed six studies reporting
prevalence of babies born small for gestational age and
the proportion of low-birthweight infants (appendix
p 5); however, none of these studies could be used
because term-SGA or preterm-SGA rates were not
reported. Table 1 shows the ﬁnal model for term-SGA.
Logit(term-SGA prevalence) increased with rising rates
of low birthweight and neonatal mortality (ﬁgure 1).
Regional random eﬀects were applied to account for
regional variations of the relations. With low
birthweight and neonatal mortality included in the
Description

Coeﬃcient (95% CI)

p

ln(LBW prevalence)

Natural log of LBW prevalence

0·997
(0·732 to 1·262)

<0·0001

Neonatal mortality
rate

Neonatal mortality rate

0·012
(0·003 to 0·022)

0·010

Population selection
dummy variable

Dummy variable to indicate facility recruitment
in setting with high institutional delivery

0·246
(–0·114 to 0·606)

0·181

Population selection
dummy variable

Dummy variable to indicate facility-based
recruitment and selection bias

0·108
(–0·203 to 0·419)

0·496

_cons

..

–4·160
(–4·968 to –3·352)

<0·0001

Adjusted R²=0·8237. LBW=low birthweight. SGA=small for gestational age.

Table 1: Final statistical model for logit(term-SGA prevalence)
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A
1

Facility-based studies
Population-based studies

India 1998
Bangladesh 2001

0

logit(term-SGA prevalence)

India-WHO 2007

Nepal-WHO 2007
Sri Lanka-WHO 2007
Niger-WHO 2004

–1

Kenya 1995

Cambodia-WHO 2007

Nepal 1999

Nepal 2004

Nepal 2003

Bangladesh 2003

Philippines-WHO 2007
Burkina Faso 2004
Burkina Faso 2006
Pakistan 2003

Ecuador-WHO 2004
Philippines 1989
Thailand 2001
Nigeria-WHO
Tanzania 2009
Angola-WHO 2004
2007
DR Congo-WHO 2004
Tanzania 2002
Pakistan 2000
Kenya-WHO 2004
Nicaragua-WHO 2004
Thailand-WHO 2007
Vietnam-WHO 2007
South Africa 2003
Brazil 1982
Brazil-WHO 2004
Mexico-WHO 2004
Cuba-WHO 2004
Brazil 2004
Uganda-WHO 2004 Brazil 1993
Peru 1995
Algeria-WHO 2004
Peru-WHO 2004
China-WHO 2007 Uganda 2005

–2

Paraguay-WHO 2004

Argentina-WHO 2004

Chile 2000

–3
1·5

2

2·5

3

3·5

4

ln(LBW prevalence)

B
1

India 1998
Bangladesh 2001

0

Nepal 1999

Nepal 2003

Bangladesh 2003
India-WHO 2007

logit(term-SGA prevalence)

Nepal 2004

Philippines-WHO 2007
Sri Lanka-WHO 2007

Burkina Faso 2004

Nepal-WHO 2007
Niger-WHO 2004

Burkina Faso 2006

–1

Pakistan 2003

Ecuador-WHO 2004

Philippines 1989

Nigeria-WHO 2007
Tanzania 2009
Tanzania 2002
Kenya-WHO 2004

Thailand 2001
Pakistan 2000
Vietnam-WHO 2007
Nicaragua-WHO 2004
Brazil-WHO 2004

Brazil 1993
Mexico-WHO 2004
Thailand-WHO 2007

Kenya 1995

Cambodia-WHO 2007
Angola-WHO 2004
DR Congo-WHO 2004

South Africa 2003

Brazil 1982

Figure 1: Scatterplots
showing the relation of
term-SGA to LBW and
neonatal mortality rate
(A) logit(term-SGA
prevalence) versus
ln(LBW prevalence).
(B) logit(term-SGA
prevalence) versus
neonatal mortality rate.
SGA=small for gestational age.
LBW=low birthweight.
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20

40
Neonatal mortality rate (per 1000 livebirths)

60

www.thelancet.com/lancetgh Vol 1 July 2013

Articles

model, socioeconomic covariates were not signiﬁcant
and, thus, not retained in the ﬁnal model. Data source
covariates were retained to control for selection bias
and data quality. Regression diagnostic plots are shown
in the appendix (p 13); the overall model ﬁt was good
(adjusted R² 0·8237).
Meta-analyses for the prevalence of babies born small
for gestational age are presented in the appendix for
moderate-to-late preterm infants (32 weeks to <37 weeks
of gestation; pp 14–16) and for early preterm infants
(<32 weeks of gestation; pp 17–18). Overall, in moderateto-late preterm infants, 22·0% were small for gestational
age (Asia 24·4%; Africa 17·0%; Latin America and the
Caribbean 22·7%; appendix p 14). Prevalence of babies
born small for gestational age in the moderate-to-late
preterm group was similar in community-based and
facility-based studies in Asia (appendix p 15), and when
restricted to high-quality studies (p 16). For early preterm
infants (born at <32 weeks of gestation), the potential for
selection bias was greater, in view of early mortality
before weighing in community-based cohorts and
incomplete data capture. In Asia, prevalence of
preterm-SGA was highest in facility-based studies (9·0%
in nine facility studies vs 2·1% in six community studies;
appendix p 17). With high-quality datasets, the overall
prevalence of babies born small for gestational age before
32 weeks of gestation was 11·0% (appendix p 18). In
sensitivity analyses, we noted no eﬀect of imputation of
missing birthweight data on the prevalence of
preterm-SGA in four Asian and two African datasets
(appendix p 9).
Figure 2 shows the estimated national prevalences of
small-for-gestational-age births in low-income and
middle-income countries for the year 2010 (a complete
list of national estimates is available in the appendix
pp 19–23). Table 2 presents the numbers and prevalence
of term-SGA, preterm-SGA, and all small-for-gestationalage births, by UN-MDG region. Prevalence of term-SGA
ranged from 5·3% in east Asia to as high as 41·5% in
south Asia, and preterm-SGA ranged from 1·2% in north
Africa to 3·0% in southeast Asia. For all small-forgestational-age births, the highest prevalence was
recorded in south Asia (44·5%), followed by sub-Saharan
Africa (25·5%) and southeast Asia (24·3%). The greatest
numbers of term-SGA infants were born in south Asia
(16·2 million) and sub-Saharan Africa (7·5 million).
Although their absolute numbers are lower, preterm-SGA
infants carry a higher risk of mortality in the newborn
and infant periods than do term-SGA infants;10 numbers
of preterm-SGA babies totalled 1·2 million in south Asia
and 0·6 million in sub-Saharan Africa. The vast majority
of small-for-gestational-age infants (87%, 28·2 million)
were born in south Asia, southeast Asia, and sub-Saharan
Africa.
Figure 3 presents prevalence data for term-SGA,
preterm-SGA, and preterm appropriate-for-gestationalage births, compared with the prevalence of babies born
www.thelancet.com/lancetgh Vol 1 July 2013

National prevalence of SGA (%)
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10–20
20–30

30–40

40–50
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Figure 2: Estimated prevalence of SGA births in 138 low-income and middle-income countries
SGA=small for gestational age.

with low birthweight. Table 2 also shows the estimated
numbers of term-SGA infants who weighed less than
2500 g at birth (term-SGA and with low birthweight), by
UN-MDG region for 2010. In all regions, the majority
(>50%) of term-SGA infants weighed 2500 g or heavier,
with high proportions of babies not low birthweight but
small for gestational age in Africa (74%) and Latin America
and the Caribbean (71%). The highest regional proportion
of low-birthweight babies was recorded in south Asia
(26%), and the prevalence of term-SGA infants was also
very high in this region (42%). Term-SGA accounted for
65% of low-birthweight babies in south Asia and
preterm birth accounted for 35%. In sub-Saharan Africa,
although preterm birth rates were similar to those in
south Asia, the rate of low-birthweight babies was lower
(14%) and preterm birth made a relatively larger
contribution to the low-birthweight metric (57% preterm
birth vs 43% term-SGA). Similarly in Latin America and
the Caribbean, preterm birth comprised a larger
proportion of the low-birthweight metric (60% preterm
birth vs 40% term-SGA). In east Asia, the proportion of
low-birthweight infants was very low (2·6%) and consisted
mainly of preterm-SGA infants. In regions with lower
rates of low-birthweight babies, such as north Africa or
east Asia, preterm birth seems the more inﬂuential
contributor to the low-birthweight metric.
Overall, in countries of low and middle income in 2010,
an estimated 43·3 million infants (36% of livebirths)
were born either preterm or small for gestational age, or
both (ﬁgure 4). Of 18 million low-birthweight infants,
59% were term-SGA whereas 41% were preterm (16%
preterm-SGA, 25% preterm and appropriate size for
gestational age).
Table 3 shows the ten countries with the largest
numbers of small-for-gestational-age infants born in
2010. An estimated 12·8 million babies were born small
for gestational age in India alone (95% CI 11·5–14·3
million), with a prevalence of 47%. Pakistan, Nigeria,
Bangladesh, China, and Indonesia had more than
1 million small-for-gestational-age babies.
e30
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Births in 2010 Prevalence (uncertainty range)
Preterm birth2
Caucasus and
central Asia

Number of births (uncertainty range)*

SGA

Term-SGA

Preterm-SGA

Preterm

SGA

1 643 000

9·2% (6·1–13·0)

15·0%
(10·6–21·4)

12·9%
(8·5–19·2)

2·1% (1·3–2·9)

151 300

East Asia

17 490 000

7·2% (5·4–9·0)

7·0%
(4·2–11·6)

5·3%
(2·7–10·1)

1·7% (1·1–2·1)

Southeast Asia

10 983 400

13·6% (9·3–18·6)

24·3%
(19·5–30·2)

21·2%
(16·7–27·1)

South Asia

38 753 000

13·3% (10·1–16·8)

West Asia

4 855 300

Term-SGA

Term-SGA
and LBW

PretermSGA

240 700
(169 800–342 400)

207 000

82 800

33 700

1 262 200

1 182 300
(720 700–1 975 000)

901 000

360 400

281 400

3·0% (2·0–4·3)

1 497 500

2 670 200
(2 143 400–3 318 900)

2 336 400

934 600

333 900

44·5%
41·5%
(40·0–49·7) (37·4–46·9)

2·9% (2·1–3·8)

5 159 300

17 350 300
(15 600 000–19 400 000)

16 200 000

6 475 100

1 150 300

10·1% (6·9–14·3)

21·8%
(17·6–27·2)

19·6%
(15·4–25·3)

2·2% (1·5–3·2)

488 200

958 100

383 200

108 900

263 100

7·4% (4·5–15·6)

21%
(16·2–27·4)

19·4%
(14·6–25·3)

1·6% (1·0–3·5)

19 500

51 000

20 400

4300

North Africa

3 543 000

7·3% (4·8–10·9)

9·6%
(6·8–13·2)

8·5%
(5·7–11·9)

1·2% (0·7–1·9)

259 200

296 000

77 000

41 600

Sub-Saharan
Africa

32 085 500

12·3% (9·5–15·8)

25·5%
(21·7–28·8)

23·5%
(19·9–26·7)

2·0% (1·4–2·8)

3 936 800

8 157 300
(6 943 600–9 215 500)

7 525 200

1 956 500

632 200

Latin America and
the Caribbean

10 844 500

8·6% (7·0–12·0)

12·5%
(9·4–16·3)

10·7%
(7·7–14·4)

1·8% (1·4–2·5)

929 300

1 374 000
(1 029 700–1 788 900)

1 180 100

342 200

193 900

120 461 300

11·3% (8·6–14·7)

27·0%
(24·1–30·5)

24·7%
(21·7–28·1)

2·3% (1·7–2·9)

13 702 800

29 654 600

10 632 200

2 780 100

Oceania

Total†

1 066 900
(863 100–1 334 300)
55 300
(42 700–72 000)
337 600
(239 400–461 400)

32 434 800
(29 001 600–36 742 300)

SGA=small for gestational age. LBW=low birthweight. *Uncertainty ranges for all estimates are included in the appendix (pp 19–23). †Total for 138 countries of low and middle income.

Table 2: Estimated prevalence and numbers of preterm and SGA infants, by UN-MDG region in 2010

100
90

Term-SGA
Preterm-SGA
Preterm-AGA
LBW

80

Prevalence (% of livebirths)

70
60
42%

50
40
24%

21%

30

20%
19%

26%

13%

20
10
0

11%
3%
10%

South Asia

14%

2%
10%

Sub-Saharan
Africa

3%
12%
11%

8%
8%

Southeast Asia

5%

11%

2%

2%

West Asia

10%
6%

Oceania

2%
7% 6%

Caucasus and
central Asia

2%

7% 8%

1%

Latin America
and the Caribbean

2%
6% 6%

6% 3%

North Africa

East Asia

Figure 3: Prevalence of SGA, preterm births, and LBW by UN-MDG region in 2010
AGA=appropriate for gestational age. SGA=small for gestational age. LBW=low birthweight.

Discussion
Our data provide national and regional estimates for the
prevalence and number of babies born small for
gestational age and the co-occurrence of small for
gestational age with preterm birth. 43·3 million infants
(36% of livebirths) in countries of low or middle income
were born either too small (small for gestational age) or
too soon (preterm), or both, in 2010. The estimated
e31

burden of babies born small for gestational age is very
high; 32·4 million neonates (27% of livebirths) are
aﬀected, of whom 29·7 million infants were born at full
term (≥37 weeks) and 10·6 million were born at term and
with low birthweight (<2500 g). Almost 3 million infants
(2%) were born preterm and small for gestational age.
The highest rates and numbers of babies born small for
gestational age were in south Asia, where more than half
www.thelancet.com/lancetgh Vol 1 July 2013
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Preterm and LBW
7·4 million

Loss of human capital
Death

Preterm
SGA (LBW)
2·8 million
Preterm AGA (LBW)
4·6 million
Term SGA (LBW) 10·6 million
Preterm AGA (not LBW) 6·3 million

Increasing risk

SGA and LBW (13·4 million)

LBW <2500 g (18 million)

Epidemiological category
Preterm “too soon” and/or SGA “too small” (43·3 million)

of babies small for gestational age are born and nearly one
in two infants are born too small. The prevalence of babies
born small for gestational age reached almost 50% in
Pakistan and India, predicted largely on national rates for
low birthweight, which were very high. The cutoﬀ for
small for gestational age at the 10th centile of the reference
population was recommended by a WHO expert
committee;5 however, a lower cutoﬀ could be considered
at the 3rd centile, which would indicate especially severe
cases of small for gestational age, particularly in highburden settings. With a 3rd centile38 cutoﬀ, the prevalence
of severe small-for-gestational-age births was 23% in
south Asia, aﬀecting 3·9 million infants (analysis not
shown). The lowest rates of babies born small for
gestational age were noted in east Asia, largely aﬀected by
data for China, where the reported low-birthweight rate
was 2·4% (WHO Regional Oﬃces, 2008).
A major challenge in estimating the global burden of
babies born small for gestational age is selection of a
common reference population. The Williams39 reference
of Californian livebirths from 1970–76 (n=2 288 806) was
recommended in 1995 by WHO6 in view of the multiracial
population, representation at lower gestational ages, and
association with survival. We chose the 1991 US birth
reference population,8 which was published after the
original WHO recommendation, because it is more
recent than the Williams reference, has a large sample
size (n=3 134 879) that better represents low gestational
ages, covers a national and diverse multiethnic
population, has well characterised methods to smooth
centile curves and exclude outlying values, and is the
most frequently cited reference in scientiﬁc literature.
Choosing a common reference for burden estimates is
important, since the estimated prevalence of babies born
small for gestational age varies substantially depending
on the reference population chosen. For example, within
a south Indian cohort, the estimated prevalence of babies
born small for gestational age ranged from 10·5%40 to
72·5%41 using the 10th centile cutoﬀ of diﬀerent reference
populations, with the Alexander reference providing a
prevalence of 56%8 (Joanne Katz, Johns Hopkins
Bloomberg School of Public Health; personal
communication). Another consideration is use of a
birthweight-for-gestation curve versus an ultrasoundbased fetal-weight curve. For preterm infants, a
birthweight-for-gestation reference might underestimate
the true prevalence of intrauterine growth restriction
because preterm infants could be small at birth because
of pathological eﬀects, which led to the preterm birth,
compared with babies who remain in utero.42 However,
ultrasound-based fetal-weight estimation methods also
have limitations. A standard proposed by WHO43 shifts
the Hadlock distribution of fetal weights for every
gestational age by a particular country’s mean birthweight
at 40 weeks, thus setting by default any population-based
small-for-gestational-age prevalence close to 10%. This
strategy only identiﬁes the most growth-restricted infants

Long-term
disability and
reduced learning
potential
Other long-term
eﬀects—eg,
stunting, higher
risk of noncommunicable
diseases

Term SGA (not LBW) 19·0 million

Term AGA 77·0 million

Figure 4: Public health implications of the burden of preterm and SGA births for 120 million births in
countries of low and middle income
AGA=appropriate for gestational age. SGA=small for gestational age. LBW=low birthweight. Adapted from
reference 37, with permission of WHO.

in that particular population, rather than establishing the
burden of suboptimum growth. Most limitations of
available fetal growth references are being addressed in
the WHO Intergrowth study, which is currently taking
place in eight geographically diverse settings and aims to
develop international growth standards to describe
optimum fetal growth and newborn nutritional status
(completion in 2014).44
Our analyses show important regional diﬀerences in
babies born small for gestational age and the composition
of low birthweight. In south Asia, rates of low birthweight
are high and many (65%) low-birthweight births are
attributable to term-SGA infants. However, in
sub-Saharan Africa and Latin America and the Caribbean,
just over 50% of low-birthweight babies are preterm.
Furthermore, low birthweight might not fully capture the
increased risk of babies born too soon or too small. The
median birthweight of an infant born at 33 weeks of
gestation is around 2500 g for the Alexander distribution;8
thus, many late preterm infants could weigh 2500 g or
heavier. Two-thirds of term-SGA infants weigh 2500 g or
more, although these babies are at lower risk of morbidity
and mortality than their low-birthweight counterparts,
particularly from non-communicable diseases in
adulthood.
Estimates of intrauterine growth restriction were
reported by de Onis and colleagues in 1998.4 These
researchers estimated that 13·7 million infants (11% of
births) in low-income and middle-income countries were
born at term and with a low birthweight, an indicator that
was a proxy for intrauterine growth restriction.
By comparison, we estimated that a total of 10·6 million

For data from WHO Regional
Oﬃces see http://www.wpro.who.
int/publications/databases/en
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Livebirths in
201016

NMR
201015

LBW
births

Preterm
births2

Term-SGA
births

Preterm-SGA Number of SGA births
births
(uncertainty range)

SGA
prevalence

1

India

27 000 000

33·1

7 507 200

3 519 100

12 000 000

784 600

2

Pakistan

4 700 000

36·1

1 232 800

748 100

2 061 300

166 800

12 800 000 (11 500 000–14 300 000) 46·9%
2 228 100 (2 012 200–2 529 800)

3

Nigeria

6 300 000

40·2

740 900

773 600

1 379 500

124 200

1 503 800 (1 275 300–1 709 100)

23·7%

4

Bangladesh

3 000 000

27·5

656 100

424 100

1 108 500

94 600

1 203 000 (1 071 800–1 369 200)

39·6%

47·0%

5

China

17 000 000

9·4

398 400

1 172 300

810 700

261 400

1 072 100 (648 300–1 817 600)

6·5%

6

Indonesia

4 400 000

15·9

485 300

675 700

891 600

150 700

1 042 300 (814 800–1 309 300)

23·8%

7

Ethiopia

2 600 000

32·4

530 400

263 400

795 700

42 300

838 000 (698 900–957 600)

32·1%

8

Philippines

2 300 000

12·6

459 500

348 900

708 900

77 800

786 700 (641 600–937 900)

33·6%

9

Democratic
Republic of
Congo

2 900 000

47·4

275 800

341 400

574 600

54 800

629 500 (523 000–754 900)

21·9%

10

Sudan

1 400 000

31·5

438 600

188 300

565 000

30 200

595 200 (485 900–696 600)

41·7%

NMR=neonatal mortality rate. LBW=low birthweight. SGA=small for gestational age.

Table 3: Top ten countries with the highest numbers of SGA infants born in 2010

babies were born at term with low birthweight in countries
of low and middle income in 2010. However, our
estimation of small for gestational age also included two
groups missing in the term and low-birthweight indicator:
preterm-SGA infants who are at substantially higher risk
of adverse outcomes;10 and babies born small for
gestational age but weighing 2500 g or more. The
estimates made by de Onis and colleagues were based on
1996 rates of low birthweight from WHO and on older
data from 1960–96, which used inputs from 60 datasets in
low-income and middle-income countries at a time when
less attention was paid to metrics for gestational age.
Recent ﬁndings show temporal changes in the distribution
of small-for-gestational-age and preterm births in lowbirthweight babies.45
Estimates of preterm, low-birthweight, and small-forgestational-age rates are imperfect because of gaps and
biases in data. The methods used to ascertain gestational
age varied between studies and might aﬀect estimation of
gestational length. We included studies meeting a priori
data-quality criteria for gestational age, and nine studies
included ultrasound measures of gestational age. In
several studies, last menstrual period was recorded
prospectively during monthly pregnancy surveillance and,
thus, this information was subject to less recall bias. We
included information from both facility-based and
community-based or population-based studies, and we
attempted to assess biases. National data were available
from Chile only.21 The WHO Global Survey was a facilitybased survey, which could be biased depending on the
nature of the facility, the number of facilities in an area,
and the proportion of deliveries that took place in the
home. We included a covariate to control for facility bias.
In community-based studies, neonatal weight is measured
after birth and, therefore, a high proportion of birthweight
data can be missing for early neonatal deaths. We excluded
datasets that had a substantial amount of missing
birthweight data (>25%), and we did sensitivity analyses
e33

with imputation of missing birthweight data.10 The
prevalence of term-SGA and preterm-SGA did not change
substantially. However, data for birthweight might have
been missing more frequently among preterm-SGA
babies, because these infants are at a higher risk of
mortality and they might have died before weighing.
Thus, our projections could underestimate the prevalence
of preterm-SGA. Furthermore, in view of the use of
birthweight rather than an ultrasound growth reference,
the prevalence of preterm-SGA could be underestimated,
because growth restriction has a relatively higher
frequency in babies who are born preterm versus those
who remain in utero for the full gestation period. Data for
maternal HIV status were limited; HIV infection can be a
risk factor for babies born small for gestational age,
although risk is not so clearly deﬁned for preterm birth.46
Finally, most of our datasets did not include data on
stillbirths, which are more likely to be associated with fetal
growth restriction and preterm birth, and our estimates
do not capture this burden.
The dearth and quality of data on both birthweight and
gestational age in countries of low and middle income
have been key barriers to quantiﬁcation of the burden of
small-for-gestational-age babies or intrauterine growth
restriction (panel). More than half of infants in lowincome and middle-income countries are never weighed
at birth, particularly those born outside of facilities,1 and
facility-based data are subject to selection biases. Inclusion
of birthweight in household surveys (eg, demographic
and health survey, multiple indicator cluster survey) since
the 1990s has improved data availability, and methods to
adjust data quality have been developed.1 Serial fetal
ultrasonography is the gold standard for diagnosis of
intrauterine growth restriction in high-resource settings,
but small for gestational age at birth is the most commonly
used indicator in countries of low and middle income.
Data for gestational age are also troublesome. In lowincome and middle-income countries, ultrasound is
www.thelancet.com/lancetgh Vol 1 July 2013
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Panel: Research in context
Systematic review
No systematic national estimates have been published of the
burden of babies born small for gestational age and its
co-occurrence with preterm birth. To identify birth cohorts with
birthweight and gestational age data required for secondary
analysis, we did a systematic literature review of Medline and
WHO regional databases with the terms: “preterm birth”,
“intrauterine/fetal growth restriction”, OR “small for gestational
age”, AND “developing countries”. We identiﬁed 45 birth cohorts
from low-income and middle-income countries with adequate
data and investigators willing to join the CHERG SGA-Preterm
Birth Working Group. After ﬁtting the statistical model with
these data, we observed a high correlation between low
birthweight and prevalence of small-for-gestational-age births.
To include more data in the model, we did an additional
literature review to identify studies that reported low
birthweight and prevalence of small-for-gestational-age births
using the 1991 US national birthweight reference (Alexander,
1991).8 We searched Medline and Scopus to identify studies
reporting either the prevalence of small-for-gestational-age and
low-birthweight births or the prevalence of small-forgestational-age babies using the Alexander reference, using
prespeciﬁed inclusion criteria. Search terms included [“fetal
growth restriction”, “intrauterine growth restriction”, OR “small
for gestational age”] AND “low birthweight”, using MESH subject
heading terms. Six reports were identiﬁed that reported
prevalence of small for gestational age and low birthweight;
however, none reported the prevalence of babies born at term
and small for gestational age (term-SGA) or preterm and small

generally not available and last menstrual period is used
to date most pregnancies, which can be aﬀected by poor
maternal recall, lactational amenorrhoea, variation in
length of menstrual cycle, or injectable contraception. Last
menstrual period has an estimated error of SD 3 weeks,
clinical assessment SD 2 weeks, and ultrasound done
before 20 weeks of gestation has an error of SD 7 days.
Under-registration of very preterm births attributable to
early death is also a problem.2
Our ﬁndings have important programmatic and
research implications for newborn health and survival,
particularly because 43% of under-5 deaths happen
during the neonatal period. Evidence for the primary
prevention of preterm birth and fetal growth restriction is
limited. In an analysis modelling high coverage of ﬁve
evidence-based interventions in countries with a high
development index, little reduction was seen in preterm
birth rates.47 However, the ﬁndings underline the
importance of further research in settings of low-income
and middle-income countries about birth spacing and
treatment
of
maternal
infections.
Nutritional
supplementation programmes (balanced protein–energy
supplementation) for women during pregnancy can
reduce the risk of small-for-gestational-age births by a
www.thelancet.com/lancetgh Vol 1 July 2013

for gestational age (preterm-SGA) and were therefore excluded.
Secondary analyses and statistical modelling were done to
estimate the prevalence of term-SGA for 138 countries of low
and middle income for the year 2010. We also estimated the
proportion of preterm-SGA using meta-analyses.
Interpretation
In the year 2010, 32·4 million (27%) small-for-gestational-age
livebirths were estimated, of which 2·8 million babies (2% of
births) were preterm-SGA. The prevalence of term-SGA ranged
from 5·3% in east Asia to 41·5% in south Asia, and preterm-SGA
ranged from 1·2% in north Africa to 3·0% in southeast Asia. Of the
18 million low-birthweight babies born every year, about 59% are
because of growth restriction in term infants and 41% are
attributable to prematurity. Previously, babies born at term and
low birthweight were a proxy for intrauterine growth restriction;
last estimates date from 1998, when about 13·7 million infants
(11% of births) in countries of low and middle income were born
at term and low birthweight, compared with our estimate of
10·6 million babies (9% of births) for the year 2010. However, the
number of babies born at term and low birthweight does not fully
capture the burden of growth restriction and misses infants born
small for gestational age above the 2500 g cutoﬀ in addition to
those who are both preterm and small for gestational age. These
babies might have increased risk of morbidity or mortality.
Globally, a huge burden of fetal growth restriction exists,
particularly concentrated in south Asia. Implementation of simple
and cost-eﬀective interventions that increase survival and reduce
morbidity of these babies born too small is an urgent priority.

third,48 although evidence of eﬀectiveness at scale is
scarce. Multiple micronutrient supplementation reduces
the risk of babies born small for gestational age by 17%;49
however, the eﬀect of supplementation varies across
populations, with diﬀering baseline rates of malnutrition
and access to obstetric care.
By contrast, interventions that improve the care and
survival of preterm and small-for-gestational-age infants
have major potential for immediate eﬀects and should be
prioritised—eg, early feeding support (initiation of
breastfeeding, alternative oral feeding methods),
kangaroo mother care,50 early detection and treatment of
neonatal infections,51 and neonatal resuscitation.52 These
common interventions improve the management of
small babies—whether due to preterm birth or
intrauterine growth restriction—and have been proven
to have great eﬀect, or are even judged standard care, in
high-income settings. Yet, these simple low-cost
interventions do not reach those small babies in the
settings of greatest need.
Moving beyond birthweight metrics alone and
delineating preterm birth and intrauterine growth
restriction are important for advancing a healthy start in
life. In 2010 in countries of low and middle income,
e34
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32·4 million neonates, or one in every four babies, were
classiﬁed as small for gestational age, closely linked to
13·7 million babies born too soon. Half of infants born
small for gestational age were in south Asia, where one
of two babies was born too small. To improve the
epidemiology and adequately monitor the eﬀect of
interventions, systems are needed urgently to better
capture and track pregnancy outcomes and to increase
the quantity and quality of both birthweight and
gestational age data. Eﬀective low-technology interventions are available now to deliver care to these most
vulnerable babies born too small or too soon.
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